Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of August 24, 2026, INDV trades at $36.84 with a market cap of $4.35B and a P/E ratio of 12.79. INDV moved -2.38% today. Year to date, INDV is +2.76%; over the trailing twelve months it is +53.31%. Its 52-week range spans $7.62 to $42.81. Analyst consensus is strong buy with an average price target of $48.00. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Indivior Pharmaceuticals, Inc. Common Stock (INDV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INDV moved -2.38% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $36.84 |
| Market Cap | $4.35B |
| P/E Ratio | 12.79 |
| EPS | $2.88 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.81 |
| 52-Week Low | $7.62 |
| Volume | 1.74M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.33B |
| Net Income | $355.00M |
| Gross Margin | 81.98% |
3 analysts cover INDV: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.00.